Safety and immunogenicity of an MF59®-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly
- 1 February 2012
- Vol. 30 (7) , 1388-1396
- https://doi.org/10.1016/j.vaccine.2011.12.009
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Vaccinate before the next pandemic?Nature, 2010
- H5N1 Influenza — Continuing Evolution and SpreadNew England Journal of Medicine, 2006
- Avian influenza vaccines: what's all the flap?The Lancet, 2006
- How prepared is Europe for pandemic influenza? Analysis of national plansThe Lancet, 2006
- Influenza pandemic preparedness: gauging from EU plansThe Lancet, 2006
- Vaccines against Avian Influenza — A Race against TimeNew England Journal of Medicine, 2006
- Establishment of multiple sublineages of H5N1 influenza virus in Asia: Implications for pandemic controlProceedings of the National Academy of Sciences, 2006
- Development and evaluation of influenza pandemic vaccinesThe Lancet Infectious Diseases, 2006
- Probable Person-to-Person Transmission of Avian Influenza A (H5N1)New England Journal of Medicine, 2005
- Selection of influenza vaccine strains and developing pandemic vaccinesVaccine, 2002